AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro


The drugmaker will pay AI therapeutics company Insitro $40 million upfront and up to $1.46 billion subject to meeting targets.

No comments:

Post a Comment